Licensing information - License requirements, fees and licensing requirements
More information can be found on the Department of Health's SB 5380 Waiver Attestation Forms webpage.
- Policy Statement PMB 20-51.1 Continuing Education Requirements During COVID-19 Response - The Podiatric Medical Board issued Policy Statement PMB 20-51, updated as Policy Statement PMB 20-51.2 then 20-51.2, and now 20-51.4, Continuing Medical Education Requirements During COVID-19 Response (PDF), to address the impact COVID-19 response measures have had on meeting the podiatric physician profession with regard to meeting the continuing medical education (CME) requirements. The board will accept online courses for meeting the CME requirements through December 31, 2022, to allow licensees to complete any remaining online courses that were started under the state of emergency.
- Continuing medical education (CME) Rules adopted
The board adopted amendments to WAC 246-922-300 and 246-922-310 regarding CME requirements for podiatric physicians. The amendments include accepting maintenance of specialty board certification as meeting the full 100-hour CME requirement, clarification on how residency training qualifies for CME, and clarification that CME activities may be completed either in-person, by remote attendance, or interactive online or prerecorded courses. The board also adopted changes to the numbers of hours required or allowed in the various CME categories. The board also added options to the activities recognized under Category 3. These changes take effect November 4, 2022.
- Opioid prescribing rules
See WAC 246-922-660 through 246-922-790 for more information on opioid prescribing specific to podiatric physicians.
The Department of Health filed an Interpretive Statement titled Clarification of Opioid Prescribing Rules, with the Office of the Code Reviser on September 20, 2019, as WSR 19-20-063 (PDF). This Interpretive Statement is a joint communication from the State Health Officer, the Board of Osteopathic Medicine and Surgery, Dental Quality Assurance Commission, Nursing Care Quality Assurance Commission, Podiatric Medical Board, and the Washington Medical Commission. The purpose of the joint communication is to help practitioners better understand the existing opioid prescribing rules.
For more information and to access additional resources, see the Department of Health's Opioid Prescribing webpage. If you have any questions, email us.